Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 1.40 trillion as of April 28, 2026. Its market cap has increased by 180.65% in one year.

Market Cap

1.40T

Enterprise Value

1.38T

Revenue

3.52B

Ranking

n/a

PE Ratio

n/a

Stock Price

14,600.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 1.40T, an increase of 2,848.22%. That is a compound annual growth rate of 15.72%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	1,400.23B	193.66%
Dec 30, 2025	476.82B	-15.13%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	69.62T
Celltrion	43.39T
ALTEOGEN	20.15T
Samsung Epis Holdings	14.13T
L&C BIO Co.,LTD	1,741.78B
Chabiotech	1,621.51B
GC Biopharma	1,598.98B
HK inno.N	1,543.98B

Market Cap Rankings